Glut-1 Expression and In Situ CD1a/CD57 Immunologic Deficit in Keratoacanthoma and Squamous Cell Carcinoma of Immunocompetent Patients

2011 ◽  
Vol 19 (3) ◽  
pp. 239-245 ◽  
Author(s):  
Daniela Cabibi ◽  
Francesco Aragona ◽  
Carla Guarnotta ◽  
Vito Rodolico ◽  
Monica Zerilli ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Glut 1 ◽  
Immunocompetent Patients

Factors Influencing Squamous Cell Carcinoma In Situ Recurrence and Implications for Treatment Choice

2018 ◽  
Vol 44 (5) ◽  
pp. 613-620 ◽  
Author(s):  
Andrew J. Matsumoto ◽  
Adam R. Schmitt ◽  
Logan M. Skelley ◽  
Christian L. Baum
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Carcinoma In Situ ◽  
Treatment Choice ◽  
Factors Influencing

scholarly journals Metastatic Squamous Cell Carcinoma of the Anus to the Lung Confirmed with Allelotyping

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Rachel Roth ◽  
Susan Moffatt-Bruce ◽  
Marino E. Leon
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Loss Of Heterozygosity ◽  
Squamous Cell ◽  
Palliative Chemotherapy ◽  
Primary Tumors ◽  
Appropriate Treatment ◽  
Metastatic Squamous Cell Carcinoma ◽  
Hematoxylin And Eosin

Histopathologic techniques are insufficient for distinguishing primary squamous cell carcinoma (SCC) from metastatic SCC, which is clinically important. A patient with SCC of the anus was found to also have SCC of the lung, and the question of metastatic versus synchronous primary diseases was raised. Immunohistochemical and hematoxylin and eosin (H&E) staining on sections of tissue could not discriminate between the two entities. Immunostain for p16 and chromogenicin situhybridization for human papillomavirus (HPV) type 16 were positive in both tumors. Additionally, allelotyping for loss of heterozygosity displayed similar findings and confirmed the histopathological impression of anal SCC metastasis to the lung. The patient was treated with palliative chemotherapy instead of additional surgical treatment. When multiple tumors are present, determining metastatic versus synchronous primary tumors is necessary for appropriate treatment. Identification can be achieved using allelotyping for loss of heterozygosity.

Pigmented squamous cell carcinoma in situ of the eyelid

2017 ◽  
Vol 58 (4) ◽  
pp. e275-e276
Author(s):  
Michelle T. Sun ◽  
Saul Rajak ◽  
Craig James ◽  
Shyamala C. Huilgol ◽  
Dinesh Selva
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Carcinoma In Situ

Pigmented Squamous Cell Carcinoma In Situ of the Conjunctiva in 5 Cases

Ophthalmology ◽  
2008 ◽  
Vol 115 (10) ◽  
pp. 1673-1678 ◽  
Author(s):  
Carol L. Shields ◽  
Ajay Manchandia ◽  
Rajeeve Subbiah ◽  
Ralph C. Eagle ◽  
Jerry A. Shields
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Carcinoma In Situ

scholarly journals Epithelial trophoblastic tumor associated with in situ squamous cell carcinoma of the cervix

2010 ◽  
Vol 46 (2) ◽  
Author(s):  
Eduardo Cambruzzi ◽  
Karla Lais Pêgas ◽  
Dennis Baroni Cruz ◽  
Pedro Guilherme Schaefer
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Trophoblastic Tumor
Sign in / Sign up

Export Citation Format

Share Document